{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:33:39Z","timestamp":1788377619132,"version":"build-2803163510"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Ablative fractional laser-assisted therapy is increasingly used to facilitate drug delivery and intensify clinical efficacy of topically applied drugs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To evaluate the effectiveness of combined ablative fractional CO<jats:sub>2<\/jats:sub> laser and topically applied 5-fluorouracil (5-FU) or verapamil hydrochloride in the treatment of hypertrophic scars (HTSs) and keloids and to examine their possible effects on TGF-\u03b21 expression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS AND METHODS<\/jats:title>\n            <jats:p>Thirty patients with HTSs and keloids were randomly treated with combined CO<jats:sub>2<\/jats:sub> laser followed by topical verapamil or 5-FU application or CO<jats:sub>2<\/jats:sub> laser monotherapy. All patients received 4 treatments at 1-month intervals. Subjective and objective assessment was obtained using the Vancouver Scar Scale (VSS). Histological changes and immunohistochemical staining for TGF-\u03b21 were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Compared with baseline, there was a significant reduction in the VSS 1 month after the last treatment session in all groups (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .05). Laser-assisted 5-FU delivery tended to show a higher extent of improvement in scar characteristics than laser-assisted verapamil hydrochloride delivery, without significance. No significant side effects were reported in all patient groups. TGF-\u03b21 expression was significantly decreased after laser sessions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Combined fractional CO<jats:sub>2<\/jats:sub> laser and topical 5-FU or verapamil hydrochloride offer a safe therapy for HTSs and keloids.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000001726","type":"journal-article","created":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T02:33:22Z","timestamp":1551494002000},"page":"536-546","source":"Crossref","is-referenced-by-count":34,"title":["The Efficacy of Combining Fractional Carbon Dioxide Laser With Verapamil Hydrochloride or 5-Fluorouracil in the Treatment of Hypertrophic Scars and Keloids: A Clinical and Immunohistochemical Study"],"prefix":"10.1097","volume":"45","author":[{"given":"Hanan H.","family":"Sabry","sequence":"first","affiliation":[{"name":"Dermatology Venereology and Andrology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherine H.","family":"Abdel Rahman","sequence":"additional","affiliation":[{"name":"Dermatology Venereology and Andrology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Hussein","sequence":"additional","affiliation":[{"name":"Dermatology Venereology and Andrology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana R.","family":"Sanad","sequence":"additional","affiliation":[{"name":"Dermatology Venereology and Andrology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghreed A.","family":"Abd El Azez","sequence":"additional","affiliation":[{"name":"Pathology, Faculty of Medicine, Benha University, Benha, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/DSS.0000000000000506","article-title":"Mechanism of action, efficacy, and adverse events of calcium antagonists in hypertrophic scars and keloids: a systematic review","volume":"41","author":"Verhiel","year":"2015","journal-title":"Dermatol Surg"},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00004630-200021030-00005","article-title":"Rating the resolving hypertrophic scar: comparison of the Vancouver Scar Scale and scar volume","volume":"21","author":"Nedelec","year":"2000","journal-title":"J Burn Care Rehabil"},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399403005817","article-title":"Skin repair and scar formation: the central role of TGF-beta","volume":"5","author":"Beanes","year":"2003","journal-title":"Expert Rev Mol Med"},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1111\/j.1742-481X.2011.00771.x","article-title":"The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring","volume":"8","author":"Chalmers","year":"2011","journal-title":"Int Wound J"},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biopha.2016.09.010","article-title":"Growth factor pathways in hypertrophic scars: molecular pathogenesis and therapeutic implications","volume":"84","author":"Lian","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"R6-20230814","first-page":"32","article-title":"Rehabilitation of burn victims. A difficult path back to normality","volume":"144","author":"Butz","year":"2002","journal-title":"MMW Fortschr Med"},{"key":"R7-20230814","first-page":"1291","article-title":"A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management","volume":"33","author":"Berman","year":"2007","journal-title":"Dermatol Surg"},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/j.1524-4725.2011.02166.x","article-title":"Current methods employed in the prevention and minimization of surgical scars","volume":"37","author":"Liu","year":"2011","journal-title":"Dermatol Surg"},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00128071-200304040-00003","article-title":"Hypertrophic scars and keloids: etiology and management","volume":"4","author":"Alster","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"R10-20230814","first-page":"54","article-title":"Intralesional 5-fluorouracil as a treatment modality of keloids","volume":"30","author":"Nanda","year":"2004","journal-title":"Dermatol Surg"},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archderm.138.9.1149","article-title":"Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments","volume":"138","author":"Manuskiatti","year":"2002","journal-title":"Arch Dermatol"},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/iwj.12455","article-title":"Role of verapamil in preventing and treating hypertrophic scars and keloids","volume":"13","author":"Wang","year":"2016","journal-title":"Int Wound J"},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-024924-4.50005-5","article-title":"Structural and lipid biochemical correlates of the epidermal permeability barrier","volume":"24","author":"Elias","year":"1991","journal-title":"Adv Lipid Res"},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jaad.2015.12.008","article-title":"Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: a critical review from basics to current clinical status","volume":"74","author":"Haedersdal","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.sder.2012.03.005","article-title":"Ablative fractional resurfacing for the treatment of traumatic scars and contractures","volume":"31","author":"Uebelhoer","year":"2012","journal-title":"Semin Cutan Med Surg"},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaad.2008.01.003","article-title":"The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing","volume":"58","author":"Alexiades-Armenakas","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/2013.jamadermatol.256","article-title":"Rapid healing of scar associated chronic wounds after ablative fractional resurfacing","volume":"148","author":"Shumaker","year":"2012","journal-title":"Arch Dermatol"},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/lsm.20860","article-title":"Fractional CO(2) laser-assisted drug delivery","volume":"42","author":"Haedersdal","year":"2010","journal-title":"Lasers Surg Med"},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4103\/0378-6323.42899","article-title":"Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids","volume":"74","author":"Margaret Shanthi","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1165\/rcmb.2015-0009OC","article-title":"Disruption of calcium signaling in fibroblasts and attenuation of bleomycin-induced fibrosis by nifedipine","volume":"53","author":"Mukherjee","year":"2015","journal-title":"Am J Respir Cel Mol Biol"},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/PRS.0b013e3181904d1b","article-title":"5-Fluorouracil treatment of problematic scars","volume":"123","author":"Haurani","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00004630-199005000-00014","article-title":"Rating the burn scar","volume":"11","author":"Sullivan","year":"1990","journal-title":"J Burn Care Rehabil"},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1097\/01.PRS.0000122207.28773.56","article-title":"The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation","volume":"113","author":"Draaijers","year":"2004","journal-title":"Plast Reconstr Surg"},{"issue":"Suppl 1","key":"R24-20230814","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1529-8019.2009.01265.x","article-title":"Fractional CO2 laser: a novel therapeutic device upon photobiomodulation of tissue remodeling and cytokine pathway of tissue repair","volume":"22","author":"Prignano","year":"2009","journal-title":"Dermatol Ther"},{"key":"R25-20230814","first-page":"774","article-title":"Low risk of postinflammatory hyperpigmentation in skin types 4 and 5 after treatment with fractional CO2 laser device","volume":"7","author":"Tan","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"R26-20230814","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/lsm.22120","article-title":"Treatment of hypertrophic scars using laser and laser assisted corticosteroid delivery","volume":"45","author":"Waibel","year":"2013","journal-title":"Laser Surg Med"},{"key":"R27-20230814","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/jocd.12163","article-title":"Ablative CO2 fractional resurfacing in treatment of thermal burn scars: an open-label controlled clinical and histopathological study","volume":"14","author":"El-Zawahry","year":"2015","journal-title":"J Cosmet Dermatol"},{"key":"R28-20230814","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10103-015-1824-4","article-title":"Treatment of hypertrophic scars and keloids by fractional carbon dioxide laser: a clinical, histological, and immunohistochemical study","volume":"31","author":"Azzam","year":"2016","journal-title":"Lasers Med Sci"},{"key":"R29-20230814","first-page":"481","article-title":"Preliminary observations on fractional ablative resurfacing devices: clinical impressions","volume":"8","author":"Waibel","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"R30-20230814","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/lsm.22055","article-title":"Clinical and molecular effects on mature burn scars after treatment with a fractional CO(2) laser","volume":"44","author":"Qu","year":"2012","journal-title":"Lasers Surg Med"},{"key":"R31-20230814","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/lsm.22102","article-title":"Fractional laser-assisted delivery of methyl aminolevulinate: Impact of laser channel depth and incubation time","volume":"44","author":"Haak","year":"2012","journal-title":"Lasers Surg Med"},{"key":"R32-20230814","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1600-0625.2010.01093.x","article-title":"Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation","volume":"19","author":"Forster","year":"2010","journal-title":"Exp Dermatol"},{"key":"R33-20230814","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00266-016-0686-x","article-title":"Dermal remodeling of burn scar by fractional CO2 laser","volume":"40","author":"Lee","year":"2016","journal-title":"Aesthet Plast Surg"},{"key":"R34-20230814","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.4081\/dr.2015.5880","article-title":"The use of chemotherapeutics for the treatment of keloid scars","volume":"7","author":"Jones","year":"2015","journal-title":"Dermatol Rep"},{"key":"R35-20230814","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.burns.2013.09.029","article-title":"Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids","volume":"40","author":"Ahuja","year":"2014","journal-title":"Burns"},{"key":"R36-20230814","first-page":"454","article-title":"Verapamil in conjunction with pressure therapy in the treatment of pathologic scar due burn injury","volume":"54","author":"Ramos-Gallardo","year":"2016","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"R37-20230814","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1524-4725.2009.01127.x","article-title":"Fractional photothermolysis for the treatment of hypertrophic scars: clinical experience of eight cases","volume":"35","author":"Niwa","year":"2009","journal-title":"Dermatol Surg"},{"key":"R38-20230814","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaad.2004.09.018","article-title":"Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study","volume":"52","author":"Kontochristopoulos","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R39-20230814","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/jocd.12099","article-title":"Evaluation of the effect of fractional CO2 laser on histopathological picture and TGF-\u03b21 expression in hypertrophic scar","volume":"13","author":"Makboul","year":"2014","journal-title":"J Cosmet Dermatol"},{"key":"R40-20230814","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/lsm.22271","article-title":"Vascular patterns in mature hypertrophic burn scars treated with fractional CO2 laser","volume":"46","author":"Connolly","year":"2014","journal-title":"Lasers Surg Med"},{"key":"R41-20230814","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1097\/00006534-200005000-00019","article-title":"The effect of superpulsed carbon dioxide laser energy on keloid and normal dermal fibroblast secretion of growth factors: a serum-free study","volume":"105","author":"Nowak","year":"2000","journal-title":"Plast Reconstr Surg"},{"key":"R42-20230814","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.matbio.2013.02.004","article-title":"Transdermal siRNATGFb1-337 patch for hypertrophic scar treatment","volume":"32","author":"Zhao","year":"2013","journal-title":"Matrix Biol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00042728-201904000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T19:36:36Z","timestamp":1692041796000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201904000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000001726","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}